Looks awesome! Something "STICKY" for new and current investors to think about. Although the fundamentals and share price are not there yet, I am all for giving Robert Segersten some slack and afford him time to allow the process marketing our products abroad. Brand awareness among customers, and carving a niche to achieve a piece of the market share in the global medical devices and instrumentation industry is currently the next phase for Solos. Much of the "leg work" has already been done by Segersten in achieving FDA-approvals and the CE Mark certification. As long-term, value investors, the next best thing to do is sit on my hands and wait. This is how the BIG MONEY is made.
Cheers!